opioids market

1. The report "Global Opioids Market, By Product Type (Codeine, Fentanyl, Morphine, Meperidine, Methadone, and Other Product Types), By Receptor Binding (Strong Agonist, and Mild to Moderate Agonist), By Application (Pain Management, Cold and Cough, Diarrhea, and Other Applications), and Region - Global Forecast to 2030" Opioids Market accounted for US$ 2.14 billion in 2020 and is estimated to be US$ 35.16 billion by 2030 and is anticipated to register a CAGR of 2.50%. The rising prevalence of the orthopedic diseases and chronic pain, opioids plays the role of pain killer which is the major propelling factor for the growth of the global market. For Instance, in 2016, as per the Office of National Drug Control Policy, opioid painkillers were the most commonly prescribed medications in the United States. Additionally, the rising awareness towards the opioids drives the growth of the target market. Moreover, the generic manufacturers rise there focuses on the abuse-deterrent formulation (ADF) properties which are another boosting factor for the growth of the global market. Furthermore, the opioids can also prescribe by the doctors for other common distressing physical conditions including breathlessness. Key Highlights:  In 2018, Allergan acquired Elastagen, to the manufacturer of skin augmentation products. Key Market Insights from the report: Opioids Market accounted for US$ 2.14 billion in 2020 and is estimated to be US$ 35.16 billion by 2030 and is anticipated to register a CAGR of 2.50%. The market report has been segmented based on product type, receptor binding, application, and region.  By product type, the global opioids market is segmented into codeine, fentanyl, morphine, meperidine, methadone, and other product types By receptor binding, the global market is classified into strong agonist, and mild to moderate agonist By application, the target market is segmented into pain management, cold and cough, diarrhoea, and other applications By region, North America region dominates the global opioids market. The united states have more opioids consumption rate. The daily dosage of the opioids per million people is higher than the 50% as compared to the other developing markets. Moreover, the Asia- Pacific region is expected to dominate the target market over the forecast period because the countries in the Asia Pacific like China and India is one of the major opioids suppliers to the United States.    Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on "Global Opioids Market, By Product Type (Codeine, Fentanyl, Morphine, Meperidine, Methadone, and Other Product Types), By Receptor Binding (Strong Agonist, and Mild to Moderate Agonist), By Application (Pain Management, Cold and Cough, Diarrhea, and Other Applications), and by Region – global forecast till 2030 To know the upcoming trends and insights prevalent in this market, click the link below: Links: https://www.prophecymarketinsights.com/market_insight/Global-Opioids-Market-By-Drug-253 The prominent player operating in the global opioids market includes Allergan, Egalet Corporation, Endo Pharmaceuticals Inc., Janssen Pharmaceuticals Inc., Mallinckrodt, Pfizer Inc., Purdue Pharma LP, Vertice Pharma LLC, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.